GDF-8 (propeptide-Fc) is a myostatin inhibitor. Myostatin is present in the healing process of muscles and its nature is to inhibit myogenesis (the process of formation of muscular tissue). Scientists have been studying a new method to enhance the repair and regeneration of both muscle and bone in certain injuries through a new recombinant myostatin propeptide.
Through the blocking of active myostatin made by a recombinant, myostatin propeptide has been able to improve muscle and bone regeneration. Myostatin inhibitors improve wound repair in cases of deep penetrant injuries on muscles and bones.
– Increased muscle mass
– Increased strength
– Decreased fat mass
– Common Dosage is 250 mcg every 5 days for 25 days
– Administered via intramuscular or subcutaneous injection.
Injection site redness and some occasional swelling of injection site.
– Unopened Vial: 36 months
– After reconstitution: Must be used in 14 days and stored between 2°C-8°C
Distributed by: Biolab Peptides